Notably, individuals with a slow NAT2 acetylator genotype were identified as a significant risk group for bladder cancer, particularly among smokers (HR: 1.31; 95% CI, 1.01–1.70) [42]. This evidence concerns the gene NAT2 and urinary bladder cancer.